Table 1.
Baseline characteristics of patients with and without a hospital inquired infection (HAI) during stroke service admission.
| No HAI (N=484) | HAI (N=84) | p-value | |
|---|---|---|---|
| Age, median y (range) | 64 (24-102) | 73 (19-95) | <0.0001 |
| Gender, No. female (%) | 211 (45.9%) | 39 (46.4%) | 0.9247 |
| Black Race, (%) | 309 (67.3%) | 57 (67.9%) | 0.9231 |
| Past Medical History, No. (%) | |||
| Coronary Artery Disease | 77 (16.8%) | 22 (26.2%) | 0.1043 |
| Diabetes | 132 (29.1%) | 36 (43.9%) | 0.0077 |
| Hypertension | 346 (75.9%) | 66 (78.6%) | 0.5936 |
| Dyslipidemia | 209 (45.7%) | 31 (36.9%) | 0.2571 |
| Atrial Fibrillation | 50 (11.0%) | 14 (16.7%) | 0.1436 |
| Congestive Heart Failure | 27 (13.0%) | 5 (17.2%) | 0.5363 |
| Stroke | 185 (40.2%) | 29 (34.5%) | 0.3260 |
| Baseline NIHSS, median (IQR) | 5 (0-31) | 12 (1-33) | <0.0001 |
| Simple TOAST | 0.1736 | ||
| Cardioembolic | 116 (25.2%) | 31 (36.9%) | |
| Large vessel disease | 97 (21.1%) | 21 (25%) | |
| Small vessel disease | 88 (19.1%) | 11 (13.1%) | |
| Cryptogenic | 114 (24.8%) | 15 (17.9%) | |
| >1 Cause | 12 (2.6%) | 1 (1.2%) | |
| Other | 33 (7.2%) | 5 (5.9%) | |
| Baseline Laboratory values | |||
| Serum Glucose, median mg/dl (IQR) | 115 (58-569) | 133 (78-481) | 0.0427 |
| Serum Leukocyte, median per mL (IQR) | 8 (0.2-18) | 8 (2.4-26.9) | 0.2024 |
| Hematocrit, median % (IQR) | 39.7(23-55.3) | 39.3 (24.7-48.6) | 0.5203 |
| Serum Platelet count, median per mL (IQR) | 222 (54-751) | 210 (10-750) | 0.1732 |
| IV tPA, No. (%) | 186 (40.3%) | 37 (44.1%) | 0.5159 |
Abbreviations: IQR, interquartile range; Baseline NIHSS, National Institutes of Stroke Scale score at admission; TOAST, Trial of Org 10172 in Acute Stroke Treatment; IV tPA, intravenous tissue plasminogen activator.